These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21286593)

  • 1. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.
    Cheng Y; Zhao L; Li Y; Xu T
    Chem Soc Rev; 2011 May; 40(5):2673-703. PubMed ID: 21286593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer-based nanoparticles for cancer therapy.
    Baker JR
    Hematology Am Soc Hematol Educ Program; 2009; ():708-19. PubMed ID: 20008257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles.
    Zhu J; Zheng L; Wen S; Tang Y; Shen M; Zhang G; Shi X
    Biomaterials; 2014 Aug; 35(26):7635-46. PubMed ID: 24927683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimer and cancer: a patent review (2006-present).
    Cai X; Hu J; Xiao J; Cheng Y
    Expert Opin Ther Pat; 2013 Apr; 23(4):515-29. PubMed ID: 23339480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current dendrimer applications in cancer diagnosis and therapy.
    Majoros IJ; Williams CR; Baker JR
    Curr Top Med Chem; 2008; 8(14):1165-79. PubMed ID: 18855703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in dendrimer-based nanomedicine development.
    Kim Y; Park EJ; Na DH
    Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Present and the Future of Degradable Dendrimers and Derivatives in Theranostics.
    Leiro V; Garcia JP; Tomás H; Pêgo AP
    Bioconjug Chem; 2015 Jul; 26(7):1182-97. PubMed ID: 25826129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
    Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
    ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies of dendrimer prodrugs.
    Kojima C
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimers for theranostic applications.
    Sk UH; Kojima C
    Biomol Concepts; 2015 Jun; 6(3):205-17. PubMed ID: 26136305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional dendrimer-modified multiwalled carbon nanotubes: synthesis, characterization, and in vitro cancer cell targeting and imaging.
    Shi X; Wang SH; Shen M; Antwerp ME; Chen X; Li C; Petersen EJ; Huang Q; Weber WJ; Baker JR
    Biomacromolecules; 2009 Jul; 10(7):1744-50. PubMed ID: 19459647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography.
    Peng C; Zheng L; Chen Q; Shen M; Guo R; Wang H; Cao X; Zhang G; Shi X
    Biomaterials; 2012 Feb; 33(4):1107-19. PubMed ID: 22061490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendrimers in the context of nanomedicine.
    Dias AP; da Silva Santos S; da Silva JV; Parise-Filho R; Igne Ferreira E; Seoud OE; Giarolla J
    Int J Pharm; 2020 Jan; 573():118814. PubMed ID: 31759101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
    Najlah M; D'Emanuele A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices.
    Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y
    Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity and in vitro transfection efficiency.
    Fant K; Esbjörner EK; Jenkins A; Grossel MC; Lincoln P; Nordén B
    Mol Pharm; 2010 Oct; 7(5):1734-46. PubMed ID: 20695423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas.
    Zhao L; Zhu J; Cheng Y; Xiong Z; Tang Y; Guo L; Shi X; Zhao J
    ACS Appl Mater Interfaces; 2015 Sep; 7(35):19798-808. PubMed ID: 26291070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Tomalia DA; Reyna LA; Svenson S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Oncological Submissions of Dendrimer.
    Soni N; Tekade M; Kesharwani P; Bhattacharya P; Maheshwari R; Dua K; Hansbro PM; Tekade RK
    Curr Pharm Des; 2017 Aug; 23(21):3084-3098. PubMed ID: 28356042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.